Study Details
Testing the Drug ESK-001 for People with Plaque Psoriasis
(IRB#: IRB_00180229)
Plaque psoriasis is a skin condition that causes dry, itchy, raised patches of skin on the body. This study will test a drug called ESK-001 to treat adults with this condition. The study wants to see if the drug will help people with the condition and is safe. People in the study will be randomly chosen to be treated with ESK-001, apremilast (a drug used to treat the same condition), or placebo. A placebo looks like the study drug but does not have the medication. Being in the study requires attending in-person visits at the study clinic for about 24 to 32 weeks. Medical tests will be done to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 years and older
- Diagnosis of psoriasis at least 6 months before study participation
- At least 10% of the body surface is covered in psoriasis
- Use specific birth control during study participation
- Able to attend in-person visits at the study clinic
Exclusion Criteria
- Diagnosis of nonplaque psoriasis
- Diagnosis of immune-related conditions, often with psoriasis such as inflammatory bowel disease
- Used topical treatments that could impact evaluation of psoriasis 2 weeks before participation
- Received phototherapy that could impact evaluation of psoriasis 4 weeks before participation
- Pregnant or breastfeeding
Will I be paid for my time?
Yes
IRB#: IRB_00180229
PI: Kristina Callis Duffin
Department: DERMATOLOGY
Approval Date: 2024-12-18 07:00:00
Specialties: Dermatology
I am Interested